Description
I help founders and owners of B2B services companies turn a lifetime of work into something larger — I back operators consolidating fragmented sectors — and I help investors and LPs fund the transformation.
I'm a Co-Founder and Partner at Nzyme, a lower-mid-market private equity platform investing in B2B services companies across Spain, Portugal and Germany. We take control positions in established, profitable, founder- and family-owned businesses and build them into category leaders through disciplined buy-and-build and by embedding technology and AI. Nzyme closed its first fund at €160M in 2025, is backed by Kibo Ventures as GP, and has Oliver Wyman as institutional strategic advisor. We've built platforms across healthcare services, accounting & tax, compliance, real-estate services and software.
Before Nzyme, I spent 20 years at Deutsche Bank and Oliver Wyman, where I executed M&A and advised clients on strategy. I hold degrees in Law, Business, Finance from ICADE and LBS. That combination, capital-markets discipline and operational strategy, is the lens I bring to every investment.
